Press "Enter" to skip to content

Tag: stocks

Season 2, Episode 15: Healthcare, Tech Stocks May Not Be As Defensive As Believed

Published May 13, 2020

With Chris Brown of Aristides Capital

Christopher Brown of Aristides Capital joins the podcast to discuss his investment strategy, which has produced positive returns every calendar year since 2008.

Update: This podcast episode has been transcribed! Read it here.

In Brown’s view, healthcare and information technology stocks should not be treated as defensive investments that will protect portfolios in times of stress — especially after their recent run-up. There are reasons many companies in this sector are overvalued and could see their shares drop as the economy begins to see further difficulties from coronavirus.

Aristides Capital has an active short book, which framed most of the second half of the conversation.  

Content Segments: 

  • Why investors’ thinking about defensive stocks may be misguided (4:49)
  • Growth stocks’ recent performance is reminiscent of the late-1990s tech bubble (7:05)
  • The concerns with healthcare stocks (11:45)
  • Background on the guest (15:07)
  • Some of the red flags short sellers look for and why the “big picture” is often more pertinent (20:22)
  • Inovio Pharmaceuticals (NASDAQ: INO) discussion (22:52)
  • CytoDyn Inc. (OTC: CYDY) discussion (25:44)
  • Vuzix Corp. (NASDAQ: VUZI) discussion (28:37)
  • Accelerate Diagnostics (NASDAQ: AXDX) discussion (30:59)
  • Insider purchases are not always a bullish indicator (35:02)
  • Tesla Inc. (NASDAQ: TSLA) discussion, at the guest’s suggestion (host didn’t want to go there originally) and why it could be an indicator for future market direction (36:17)
  • Reasons to be bearish on markets and the economy (39:17)
  • How to protect your portfolio against inflation (42:13)

Highlights From Our YouTube Channel

For more information on the guest:

Not intended as investment advice.

Leave a Comment

Season 2, Episode 12, Transcribed: The Next Stage of the ‘Market Melt-Up’ With David Hunter

Published May 6, 2020

Nathaniel E. Baker 0:36
David Hunter, Chief macro strategist at contrarian macro advisors. You were on the show last summer in August if memory serves, and you told listeners about your idea that there would be a dramatic melt up that would be caused by central bank liquidity, injections and other measures. And anybody who’s been paying attention to markets in the last couple of weeks, could reasonably point out that this is exactly what’s happened here with the Fed, and other central banks, mainly the Fed, stepping in to combat the coronavirus impact, and unleashing all kinds of liquidity. So, I guess that would be the first question for you is where we stand with this. And if this is indeed the start of this melt up?

David Hunter 1:37
Sure. Yeah, I think this is definitely the start of what I think will eventually become a parabolic melt up into a secular top. And in all honesty, when we talked last, I guess, late August, I didn’t anticipate the coronavirus by any means and didn’t anticipate that we’d get down under 2200 on the S&P, I thought we might in fact in January, February, March. I was talking about January, February, early March, I was talking about a correction back to 3000, maybe 2900. But I certainly didn’t see the the cascade that we we got. So, you know, the coronavirus certainly affected the path. But my target of 4000 plus on the S&P, which I had last summer is still my target today. We had another leg down. It took us down to a deeper bottom. But I think it didn’t change the fact that we are going to have this final melt up into a secular top, a top that I expect to be the high watermark for decades to come.

The full transcript is available to premium subscribers. Sign up here and get the full transcript sent to you.

MoreSeason 2, Episode 12, Transcribed: The Next Stage of the ‘Market Melt-Up’ With David Hunter
Leave a Comment

Contrarian Investor Virtual Conference No. 2 Set For June 3, With Special Discount For Listeners

Published May 5, 2020

The Contrarian Investor Podcast, in partnership with ValueWalk.com, will host its second virtual investment summit on Wednesday at 9:30 a.m..EST. The event will last about two hours and feature exclusive stock picks from contrarian investors.

Buy tickers here. There is a special discount for listeners of this podcast: Add the promotional code “contrarianpod” at checkout to receive an extra 10% off.

Ten percent (10%) of proceeds from this event will be donated to the CDC Foundation to help the emergency response to the coronavirus.

Read about the inaugural event here and how the ideas presented moved markets, creating an instant payoff for attendees who acted quickly!

How it works: A select group of investment professionals will present one (1) fresh stock pick each. These ideas must be contrarian in nature to qualify. Presenters get up to 20 minutes to introduce their idea, including slide decks if necessary. They are then asked to talk through some details by Nathaniel Baker, host of the podcast. Finally, audience members can ask questions through the webinar’s interface. Presentation materials, video recording of the event and contact information will be made available to attendees.

Not sure about your finances or schedule? We understand – tell us and you can receive a full refund up to the day before the conference.

Featuring the following presenters*:

  • Grizzly Research founder- Identity will be revealed in podcast and interview in the week before the Conference: short equity.
  • Jonathan Boyar of Boyar Value Group will present a high conviction long idea.
  • Andreas Aen, Symmetry Invest A/S: a stock pick in the “mini conglomerate” space.
  • David Neuhauser, Livermore Partners: long idea, metals and mining.

Attendance is limited. First come/first serve. 

Interested parties may email info@valuewalk.com or call +1-973-685-6523 for more information.

Leave a Comment